microRNA-567 INHIBITS CELL PROLIFERATION, MIGRATION AND INVASION BY TARGETING FGF5 IN OSTEOSARCOMA

被引:33
作者
Liu, Daodong [1 ]
Zhang, Chaoju [1 ]
Li, Xiaolin [2 ]
Zhang, Hongmei [3 ]
Pang, Qixiong [1 ]
Wan, An [1 ]
机构
[1] Yangtze Univ, Clin Coll 3, Jingzhou Hosp Tradit Chinese Med, Dept Orthopaed, 172 East Jiangjin Rd, Jingzhou 434000, Hubei, Peoples R China
[2] Yangtze Univ, Sch Med, Dept Orthopaed, Jingzhou, Hubei, Peoples R China
[3] China Acad Chinese Med Sci, Wangjing Hosp, Dept Orthopaed, Beijing, Peoples R China
来源
EXCLI JOURNAL | 2018年 / 17卷
关键词
osteosarcoma; miR-567; FGF5; proliferation; migration and invasion; BREAST-CANCER; METASTASIS; EXPRESSION; CARCINOMA; KI-67;
D O I
10.17179/excli2017-932
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
MicroRNAs (miRNAs) have been widely reported to have important regulatory roles in various human tumors, including osteosarcoma (OS). The aim of this study was to focus on the role of less well-known miRNA-567 (miR-567) in OS. We found the expression of miR-567 was significantly reduced in OS tissues and cell lines (MG-63, U2OS and Saos-2) compared with the adjacent normal tissues and normal osteoblastic cells (hFOB), respectively. Moreover, exogenous miR-567 overexpression inhibited OS cell proliferation, migration and invasion by CCK-8, Transwell assays, respectively. We further explored the mechanism underlying the suppressive effects of miR-567 on OS cells and identified a potential target of miR-567 binds to the 3' UTR of fibroblast growth factor 5 (FGF5) using TargetScan program. Furthermore, enforced expression of miR-567 decreased the expression of FGF5 in both MG-63 and U2OS cells using luciferase reporter assay and Western blotting. We also showed that overexpression of FGF5 could partially antagonize the suppressive effects of miR-567 on OS cell proliferation, migration and invasion. Taken together, our data indicated that miR-567 may function as a tumor suppressor by negatively regulating FGF5 and be potential therapeutic targets for the treatment of OS.
引用
收藏
页码:102 / 112
页数:11
相关论文
共 30 条
[11]   Current treatment of osteosarcoma [J].
Ferguson, WS ;
Goorin, AM .
CANCER INVESTIGATION, 2001, 19 (03) :292-315
[12]  
Hanada K, 2001, CANCER RES, V61, P5511
[13]   The hallmarks of cancer [J].
Hanahan, D ;
Weinberg, RA .
CELL, 2000, 100 (01) :57-70
[14]   MicroRNAs in cancer: biomarkers, functions and therapy [J].
Hayes, Josie ;
Peruzzi, Pier Paolo ;
Lawler, Sean .
TRENDS IN MOLECULAR MEDICINE, 2014, 20 (08) :460-469
[15]   Osteosarcoma of the jaw in children and young adults [J].
Huh, Winston W. ;
Holsinger, F. Christopher ;
Levy, Alejandro ;
Palla, F. Shana L. ;
Anderson, Peter M. .
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2012, 34 (07) :981-984
[16]   Ki-67 is a prognostic parameter in breast cancer patients: results of a large population-based cohort of a cancer registry [J].
Inwald, E. C. ;
Klinkhammer-Schalke, M. ;
Hofstaedter, F. ;
Zeman, F. ;
Koller, M. ;
Gerstenhauer, M. ;
Ortmann, O. .
BREAST CANCER RESEARCH AND TREATMENT, 2013, 139 (02) :539-552
[17]   Fibroblast growth factors: from molecular evolution to roles in development, metabolism and disease [J].
Itoh, Nobuyuki ;
Ornitz, David M. .
JOURNAL OF BIOCHEMISTRY, 2011, 149 (02) :121-130
[18]   Regulation of the p27Kip1 tumor suppressor by miR-221 and miR-222 promotes cancer cell proliferation [J].
le Sage, Carlos ;
Nagel, Remco ;
Egan, David A. ;
Schrier, Mariette ;
Mesman, Elly ;
Mangiola, Annunziato ;
Anile, Corrado ;
Maira, Giulio ;
Mercatelli, Neri ;
Ciafre, Silvia Anna ;
Farace, Maria Giulia ;
Agami, Reuven .
EMBO JOURNAL, 2007, 26 (15) :3699-3708
[19]   Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method [J].
Livak, KJ ;
Schmittgen, TD .
METHODS, 2001, 25 (04) :402-408
[20]   Fibroblast growth factor signaling controlling osteoblast differentiation [J].
Marie, PJ .
GENE, 2003, 316 :23-32